Literature DB >> 17352094

Results of directly observed treatment for tuberculosis in Ensenada, Mexico: not all DOTS programs are created equally.

P Radilla-Chávez1, R Laniado-Laborín.   

Abstract

SETTING: Tuberculosis (TB) program in Ensenada, Mexico.
OBJECTIVE: To evaluate the impact of the DOTS strategy on adherence and cure rates in everyday practice.
DESIGN: Retrospective analysis of 629 patients diagnosed with TB. MEASUREMENTS AND
RESULTS: A total of 70% of the patients under directly observed treatment (DOT) were cured vs. 72.8% of those under self-administered treatment (SAT, P = 0.57). There was no difference on the length of therapy according to treatment regimen (4.82 +/- 2.41 for DOT vs. 4.93 +/- 2.16 for SAT, P = 0.61); 16.8% of patients under DOT abandoned treatment vs. 14.1% in the SAT group (P = 0.40). Logistic regression analysis confirmed the previous findings, with length of treatment under 6 months being the strongest predictive variable for treatment failure (OR 18.8, P < 0.00). The type of regimen (DOT vs. SAT) was not predictive of treatment failure (OR for failure for SAT regimen 0.65, P = 0.14).
CONCLUSIONS: Cure and completion of treatment rates in our population under study did not differ significantly when comparing DOT vs. SAT. Those in charge of the DOTS programs in a given country need to assess which are the most important ingredients for success in their particular program.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17352094

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Risk Stratification and Factors Associated with Abandonment of Tuberculosis Treatment in a Secondary Referral Unit.

Authors:  Wanessa da Silva Peres Bezerra; Everton Ferreira Lemos; Thiago Nascimento do Prado; Larissa Taemy Kayano; Stefany Zacarin de Souza; Cláudia Elizabeth Volpe Chaves; Anamaria Mello Miranda Paniago; Albert Schiaveto de Souza; Sandra Maria do Valle Leone de Oliveira
Journal:  Patient Prefer Adherence       Date:  2020-12-03       Impact factor: 2.711

Review 2.  Treatment of drug-susceptible tuberculosis among people living with human immunodeficiency virus infection: an update.

Authors:  April C Pettit; Bryan E Shepherd; Timothy R Sterling
Journal:  Curr Opin HIV AIDS       Date:  2018-11       Impact factor: 4.283

3.  Association of Pulmonary Tuberculosis and HIV in the Mexican Institute of Social Security, 2006-2014.

Authors:  David Alejandro Cabrera-Gaytán; María Del Rosario Niebla-Fuentes; Rosario Padilla-Velázquez; Gabriel Valle-Alvarado; Lumumba Arriaga-Nieto; Teresita Rojas-Mendoza; Ulises Rosado-Quiab; Concepción Grajales-Muñiz; Alfonso Vallejos-Parás
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

4.  Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.

Authors:  J L Burgos; J G Kahn; S A Strathdee; A Valencia-Mendoza; S Bautista-Arredondo; R Laniado-Laborin; R Castañeda; R Deiss; R S Garfein
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 3.427

5.  Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.

Authors:  William J Burman; Mark F Cotton; Diana M Gibb; A Sarah Walker; Andrew A Vernon; Peter R Donald
Journal:  PLoS Med       Date:  2008-08-19       Impact factor: 11.069

6.  Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.

Authors:  Narges Alipanah; Leah Jarlsberg; Cecily Miller; Nguyen Nhat Linh; Dennis Falzon; Ernesto Jaramillo; Payam Nahid
Journal:  PLoS Med       Date:  2018-07-03       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.